A detailed history of Nuveen Asset Management, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 411,750 shares of GH stock, worth $13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
411,750
Previous 1,309,719 68.56%
Holding current value
$13 Million
Previous $37.8 Million 75.04%
% of portfolio
0.0%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$22.3 - $36.29 $20 Million - $32.6 Million
-897,969 Reduced 68.56%
411,750 $9.44 Million
Q2 2024

Aug 09, 2024

BUY
$16.07 - $31.84 $7.91 Million - $15.7 Million
492,210 Added 60.21%
1,309,719 $37.8 Million
Q1 2024

May 13, 2024

SELL
$17.13 - $26.91 $2.09 Million - $3.28 Million
-122,021 Reduced 12.99%
817,509 $16.9 Million
Q4 2023

Feb 14, 2024

BUY
$21.58 - $29.5 $3.93 Million - $5.37 Million
181,946 Added 24.02%
939,530 $25.4 Million
Q3 2023

Nov 14, 2023

SELL
$25.8 - $39.97 $664,685 - $1.03 Million
-25,763 Reduced 3.29%
757,584 $22.5 Million
Q2 2023

Aug 14, 2023

BUY
$20.94 - $38.01 $10.6 Million - $19.2 Million
504,070 Added 180.49%
783,347 $28 Million
Q1 2023

May 15, 2023

SELL
$22.92 - $33.76 $4.63 Million - $6.82 Million
-201,937 Reduced 41.96%
279,277 $6.55 Million
Q4 2022

Feb 14, 2023

SELL
$25.44 - $59.78 $1.15 Million - $2.7 Million
-45,170 Reduced 8.58%
481,214 $13.1 Million
Q3 2022

Nov 14, 2022

SELL
$43.66 - $61.0 $8.46 Million - $11.8 Million
-193,845 Reduced 26.91%
526,384 $28.3 Million
Q2 2022

Aug 15, 2022

SELL
$28.82 - $77.35 $28.9 Million - $77.6 Million
-1,003,327 Reduced 58.21%
720,229 $29.1 Million
Q1 2022

May 16, 2022

SELL
$48.25 - $100.49 $13.9 Million - $29 Million
-288,576 Reduced 14.34%
1,723,556 $99.4 Million
Q4 2021

Feb 14, 2022

SELL
$88.71 - $120.43 $23 Million - $31.2 Million
-259,271 Reduced 11.41%
2,012,132 $201 Million
Q3 2021

Nov 12, 2021

BUY
$98.77 - $132.17 $14 Million - $18.8 Million
142,210 Added 6.68%
2,271,403 $284 Million
Q2 2021

Aug 16, 2021

SELL
$109.77 - $165.68 $19.7 Million - $29.7 Million
-179,459 Reduced 7.77%
2,129,193 $264 Million
Q1 2021

May 17, 2021

BUY
$127.04 - $179.1 $30.8 Million - $43.5 Million
242,682 Added 11.75%
2,308,652 $352 Million
Q4 2020

Feb 16, 2021

SELL
$99.96 - $135.93 $81.4 Million - $111 Million
-813,974 Reduced 28.26%
2,065,970 $266 Million
Q3 2020

Nov 16, 2020

SELL
$80.32 - $111.8 $9.46 Million - $13.2 Million
-117,813 Reduced 3.93%
2,879,944 $322 Million
Q2 2020

Aug 14, 2020

BUY
$60.49 - $97.5 $86.3 Million - $139 Million
1,426,318 Added 90.77%
2,997,757 $243 Million
Q1 2020

May 14, 2020

BUY
$59.04 - $88.81 $9.14 Million - $13.7 Million
154,824 Added 10.93%
1,571,439 $109 Million
Q4 2019

Feb 14, 2020

SELL
$59.49 - $82.78 $250,036 - $347,924
-4,203 Reduced 0.3%
1,416,615 $111 Million
Q3 2019

Nov 14, 2019

BUY
$62.59 - $110.3 $11.7 Million - $20.6 Million
187,152 Added 15.17%
1,420,818 $90.7 Million
Q2 2019

Aug 15, 2019

BUY
$63.94 - $91.11 $78.9 Million - $112 Million
1,233,666 New
1,233,666 $107 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.24B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.